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The immune system when acts against self-molecules results in an imbalance in immunologic 
tolerance leading to the development of several autoimmune diseases such as rheumatoid 
arthritis, asthma, ulcerative colitis, type 1 diabetes and multiple sclerosis. Improved recognition 
of the mechanisms of autoimmune diseases has led to the advancement of the management of 
these diseases. The principal mediators of autoimmune diseases are inflammatory molecules.  
The herbal medicines due to their anti-oxidant and anti-inflammatory properties have an 
important role in the management of autoimmune diseases. Crocin is the principal chemical 
component extracted from saffron which is a medicinal plant. This review focuses on the 
therapeutic effects of Crocin in various autoimmune diseases. 
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Introduction 
The immune system consists of cellular and soluble protein components that protect our body 
against various infections and cancers by identifying and neutralizing infectious agents or 
cancer cells. When the immune system leads to a hyperactive immune response against foreign 
molecules and the body’s cells and proteins the result can be severe. The reaction against self-
molecules resulting in infiltrations of the inflammatory cells and tissue destruction can cause 
one of the various forms of autoimmune diseases. Autoimmune diseases (ADs) are a group of 
chronic disease with relatively high prevalence in young people and have a significant impact 
on health care costs. ADs vary significantly in the susceptible organs they impact and in their 
clinical symptoms and signs with some being restricted to specific tissues. In some cases, the 
immune response is precise to a specific cell type [e.g. oligodendrocytes in multiple sclerosis 
(MS) or pancreatic β cells in type 1 diabetes (T1DM)], but it will be able to target a wider range 
of cells and tissues (1, 2). Like many other complex disorders, genetic and environmental 
factors play an important role in the development of ADs. Polymorphisms in different genes 
result in reduced threshold or faulty regulation for T cells and B cells activation. Besides, 
environmental agents can induce the activation of self-reactive cells that can get out of control 
and are reacts against self-antigens(2). 
One of the phenomena associated with autoimmune diseases is efferocytosis. This phenomenon 
involves removing the remains of apoptosis cells by phagocytic cells. If the efferocytosis is 
impaired the apoptotic remnants of cells can trigger auto-immune responses such as systemic 
lupus erythematosus (SLE) or rheumatoid arthritis (RA). One of the factors that can impair the 
efferocytosis phenomenon is the impairment of innate immunity receptors such as C1q which 
plays an important role in phagocytosis. When the efferocytosis is impaired, the remains of 
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apoptotic cells can act as the auto-antigen for the immune system and can cause self-acting 
responses to these antigens as seen in various autoimmune diseases (3-5).   
Cytokines are one of the key factors in the initiation and regulation of immune responses. The 
cytokine network is known as one of the most complex and precise biological networks in the 
immune system that directly or indirectly impacts a wide range of immune and non-immune 
cells. It is clear that if a cytokine network is impaired, the result can be a variety of spectrum 
of immune disorders, including autoimmune diseases. The classic immune response includes 
Th1, Th2 and Th17, each of which has its specific cytokines and functions. Th1 responses were 
centered on interferon-gamma (IFN-γ) and interleukin-12 (IL-12) cytokines which trigger 
cellular immune responses. While Th2 and Th17 responses result in allergic responses based 
on IL-4, IL-5 and IL-13, and neutrophil rich responses based on IL-17, respectively. Most 
autoimmune diseases have been identified by an impaired balance between Th1, Th2 and Th17 
responses. On the other side, the cytokine network can trigger or suppress immune responses. 
Immune suppressive cytokines include IL-10, TGF-β and their main role is suppression of 
immune responses. Changes in the balance of inflammatory cytokines such as IFN-γ, IL-2 and 
IL-12 and immunosuppressive cytokines can be one of the main reasons for not adequately 
suppressing the immune system against auto-antigens leading to various autoimmune disorders 
(6-8). 
The use of natural products is recognized as a helpful strategy for the management of various 
diseases from ancient to the present time due to their low toxicity and relatively strong efficacy. 
There is growing evidence that herbals have numerous therapeutic impacts in different 
disorders such as cancers, neurodegenerative diseases and diabetes. 
Saffron (Crocus sativus L.) Stigmas contain secondary metabolites such as anthocyanins, 
flavonoids, terpenes and carotenoids. Crocin and crocetin are the two main carotenoids of 
saffron. Numerous studies on the pharmacological effects of Crocin have confirmed 
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antidepressant (9), anti-atherosclerotic (10), anti-platelet aggregation (11), renoprotective (12), 
anti-tumor (13) and anti-oxidant (14, 15) properties. Crocin has also been reported to have 
protective effects against gentamicin-induced nephrotoxicity (16). Crocin represses microglial 
activation and reduces the inflammation-induced neurotoxicity in rats (10).In this review, we 
assess the applications of Crocin for the management of ADs. 
Crocin 
Saffron (Crocus sativus L.) belongs to a monocotyledon species of the Iridaceae family (17). 
Saffron is cultivated in many areas of the world such as Iran, India, Greece, Spain, Turkey, 
Italy, Azerbaijan and China (18). Saffron is the most important part of the stigma and includes 
various secondary metabolites such as flavonoids, terpenes, carotenoids and anthocyanins. 
Chemical analysis has identified Crocin, picroCrocin, crocetin and safranal as the most 
bioactive compounds of saffron. The main metabolites of saffron are carotenoids and are 
responsible for the color and taste of the spice (19). The quality of the saffron used as a food 
coloring and flavouring agent or as a medicinal herb is mainly based on four bioactive 
components which are safranal, picroCrocin, crocetin and Crocin. They are responsible for its 
odor, bitter taste and intense red color (20). Crocin (hydrosoluble) is obtained from the 
esterification of crocetin with sugars and form crystals with a melting point of 186°C. It forms 
6% - 16% of the dry stigmas (21, 22).There are five types of -Crocin (Figure 1). Most of the 
Crocins except Crocin-1 are found in cis-trans isomeric forms (23). Crocins have a glycoside 
carotenoid structure and include trans-crocetin diester of gentiobiose, trans-crocetin ester of 
glucose-gentiobiose, trans-crocetin ester of gentiobiose, a cis-crocetin diester of gentiobiose, 
trans-crocetin diester of glucose and cis-crocetin ester of glucose-gentiobiose (18, 19). Masi et 
al. studied the properties of  twenty-five different types of Crocins from Italy and Iran and they 
reported the total dry mass concentration of Crocin ranged between 302 to 548 mg/g, which 
was dependent on the geographical origin of the Crocin (24).  
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There is a growing interest in the isolated components of saffron on human health due to their 
high anti-oxidant ability and potent anti-inflammatory effects by following mechanisms:  lipid 
peroxidation reduction, diazinon (DZN) inhibition, inflammatory cytokines and neuronal 
damage markers reductions due to its free radical scavenging activity.  (25).  
Anti-oxidant and anti-inflammatory properties of Crocin 
Reactive oxygen species (ROS) are the products of cellular metabolism which can change 
redox balance. Alterations in intracellular redox can affect various cell functions since most of 
the stress response systems and apoptotic signaling pathways are susceptible to redox 
environment (26).  
In a DPPH (2,2-diphenyl-1- picrylhydrazyl) free radical scavenging to investigate the effect of 
safranal and Crocin showed that these compounds can donate an H atom to the DPPH radical. 
Safranal and Crocin displayed a high free radical scavenging activity, 34% and 50% for 500 
ppm solution in methanol, respectively. Studies have proven that Crocin at the concentration 
of 500 lM could meaningfully reduce ROS production following either 24 and 48 hours 
treatment of the myeloma cell line U266B1 in the presence of Crocin. The cellular damage 
produced by ROS has been associated with many disorders such as cancer and 
neurodegenerative disorders. Therefore anti-oxidants’ mechanisms discovery is a key role in 
the management of oxidative stress-related disorders (13). 
Crocin scavenges free radicals (e.g. superoxide anions) and so could potentially have a 
protective role for cells against oxidative stress. Crocin is suitable for sperm cryopreservation 
and in protecting hepatocytes from toxins. Because of its potent anti-oxidant property, it could 
be suitable in the therapy of neurodegenerative disorders(27). Alterations in the enzyme 
activity and the level of translation in the cellular redox system such as glutathione peroxidase 
(GPx), glutathione S-transferase (GST), catalase and superoxide dismutase (SOD) are shown 
as potential mechanisms. Saffron extracts have different mechanisms of action such as 
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affecting signaling pathways of free radicals in the monocytes, interaction with enzymes 
(peroxidases) and inhibition of ROS during interaction of a varied range of proteins with anti-
oxidant compounds (28).  
Crocin can significantly reduce the size of brain ischemia, decrease malondialdehyde (MDA) 
level and increase GPx and SOD activities. MDA has been known as a biomarker of oxidative 
stress (29). The endoplasmic cell (ER) is closely related to the oxidative stress of the cell; 
changes in the level of mRNA expression of the ER stressors including BiP, XBP-1/s, CHOP 
and PERK are associated with many stress-related illnesses such as autoimmune diseases and 
cancer. Crocin is considered as an inhibitor of stress by inducing ER by mRNA expression of 
these genes as well as ER stress inhibition by reduction of malondialdehyde and nitric oxide 
(NO) in disorders of the neuronal cells (30). Liver damages caused by oxidative xenobiotic 
drugs can be potentially reversed by Crocin treatment. Studies have shown that Crocin-treated 
rats show a higher SH level than their controls groups in a dose-dependent manner which 
suggests that Crocin helps to refill of the total thiol pool(31). 
The anti-inflammatory effects of saffron are based on its anti-oxidant and free radical 
scavenging properties that appear to be related to crocetin and Crocin. All inflammatory 
disorders are associated with a release of ROS species with proinflammatory molecules 
produced and transported to all tissues. For instance, the system of monocytes and 
macrophages, together with the endothelial cells and platelets regulates both intrinsic immune 
responses and inflammatory responses by delivering cytokines and ROS in cardiovascular 
diseases. The natural amounts of the most important free radical scavengers, glutathione S-
transferase (GST), glutathione reduction (GSH), glutathione reductase-dependent NADPH 
(G.red-NADPH), glutathione peroxidase (GSHPx), catalase ( CAT) and superoxide dismutase 
(SOD) are reduced in most of the diseases related to immune system (Figure 2) (32). 
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Treatment of autoimmune diseases 
ADs are a heterogeneous group of disorders that involve susceptible organs (33) whose 
incidence is increasing worldwide. In this study effects of Crocin on ADs such as rheumatoid 
arthritis, type 1 diabetes, ulcerative colitis and multiple sclerosis are reviewed. Crocin was 
suggested as a candidate herbal medicine for preventing and treating ADs (Table1). 
 
Rheumatoid arthritis (RA) 
RA is a chronic systemic autoimmune disease characterized by the inflammation of the 
synovial membranes and destruction of articular cartilages (34). Around 1-2% of the population 
worldwide is affected by RA which carries significant morbidity and mortality. RA is common 
among women in comparison to men. The age of incidence is around 40–60 years of age. 
Juvenile cases of RA are also reported (35). The exact pathogenesis of RA is still largely 
unknown.  
Studies show that proinflammatory cytokines are responsible for initiating several 
inflammatory and autoimmune diseases. Cytokines (e.g. TNF-α, IL-1β) play a key role in the 
development of RA(36). Several herbal medicines and their isolated components including 
Crocin are used in the management of arthritis with the fewer side-effects(37). Animal models 
of RA are used to evaluate the impact of anti-arthritic medications and for investigating the 
pathogenesis of the disease (38). 
Crocin therapy significantly reduced the RA symptoms in rats including reduced paw 
inflammation arthritis, reduced chondrocyte death, joint inflammation, paw swelling, reduced 
arthritis score, bone and cartilage destruction in a dose-dependent method. Also, Crocin 
administration reduced the serum levels of MMPs (MP-1, MMP-3, MMP-13) and pro-
inflammatory cytokines (TNF-a, IL-6, CXCL8 and IL-17) in a dose-dependent manner(39).  
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Li et al. studied the effects of Crocin on arthritis in the human fibroblast-like synoviocytes 
(FLS) and CIA in mice. They found that Crocin treatment significantly reduced the expression 
of TNF-α, IL-1β and IL-6 in human FLS induced by LPS. In vivo studies showed that plasma 
concentrations of IL-1β, IL-6 and TNF-α were reduced in Crocin-treated CIA group compared 
to the control group. Authors studied the effects of Crocin (500 μM ) on NF-κB signaling in 
FLS and observed that these cells showed lower amounts of p-IκBα caused by LPS, p65 and 
p-IκB kinase (IKK) α/β comparative to the untreated cells. Besides, they showed that Crocin 
treatment significantly reduced plasma amounts of IL-1β, IL-6 and TNF-α in CIA mice. 
Therefore, their study proved that Crocin can inhibit the production of IL-1β, IL-6 and TNF-α 
by inhibiting the NF-κB activation via its interaction with IKK (40).  
Hemshekhar et al studied the antiarthritic effects of Crocin. They found that Crocin efficiently 
neutralized the increased serum amounts of enzymatic (MMP-3, MMP-9, MMP-13 and 
hyaluronidases) and non-enzymatic (IL-1b, COX-2, PGE2, NF-kB, IL-6, TNF-a, and ROS) 
inflammatory mediators. Also, they found that Crocin improves the anti-oxidant status of the 
system (CAT, GSH, GST and SOD). It protected the bone erosion by suppressing the increased 
levels of bone joint cathepsin-D, exoglycosidases and tartrate-resistant acid phosphatases (41). 
 
Ulcerative colitis (UC)  
UC is a chronic inflammatory disorder and its incidence is increasing worldwide (42). UC 
results in mucosal inflammation starting from the rectum and extending to proximal segments 
of the colon (43). UC is characterized by interchanging periods of intense inflammation and 
long periods of remission in the colon (44). Kawabata et al studied the effects of Crocin in the 
inhibition of colitis-associated colon carcinogenesis in mice. They showed that dietary Crocin 
inhibited the progression of chemically-induced colonic adenocarcinomas.  It suppressed the 
immunohistochemical expression and proliferation of NF‐κB as well as increased the 
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expression of the Nrf2 gene in adenocarcinoma cells. On the other hand, dietary Crocin 
inhibited dextran sodium sulphate (DSS) ‐induced colitis and reduced the expression of 
inflammatory cytokines genes (TNF‐α, NF‐κB, IL-1 β, IL‐6, IFN‐γ, COX‐2) and inducible 
expression iNOS gene(45). Khodir AE et al studied the anti-ulcerogenic and the coloprotective 
effects of Crocin against experimentally-induced UC in the rat. Crocin and felodipine were 
administrated for eight days. The results showed that Crocin had significant protective effect 
against experimentally-induced colonic damage in rats as well as anti-ulcerogenic and 
coloprotective effects. Moreover, Crocin significantly inhibited inflammatory, oxidant and 
apoptotic signaling pathways in the rat by increasing colon anti-oxidant defenses (Nrf2, Heme 
Oxygenase-1 signaling). It also reduced colon TNF-α and Ca+2 contents with down-regulation 
of caspase-3 expression. These results demonstrated that Crocin has anti-inflammatory, anti-
oxidant and antiapoptotic properties resulting in anti-ulcerogenic and coloprotective effects 
(46). Rezaei et al. investigated the therapeutic effects of Crocin against chemically induced 
colitis in mice. They showed that Crocin treatment reduced colitis symptoms in mice including 
diarrhea, body weight loss, colon shortening and rectal bleeding. Histology of colon tissues 
showed that Crocin effectively reduced colon histopathological score through inhibiting anti-
inflammatory responses in chemically-induced colitis mice. These studies demonstrate the 
potential therapeutic effect of Crocin against colitis (47).  
 
Type 1 diabetes (T1DM)  
T1DM is a chronic inflammatory disease where autoreactive T-cells and monocytic cells 
infiltrate into pancreatic islets destroying insulin-producing β cells causing hyperglycemia (48) 
Hyperglycemia induces ROS production which results in an imbalance between the production 
of ROS and anti-oxidant defensive mechanisms causing oxidative stress (49). In diabetes, the 
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free radicals cause damage to many organic substrates such as proteins, carbohydrates nucleic 
acids and lipids of the host cells resulting in various diabetes complications. ROS affects the 
β-cells as a result of activating the transcription factor NF-κβ in the macrophages (50).  
Altinoz et al. demonstrated the impact of Crocin in the management of cardiovascular 
complications by reducing oxidative stress in diabetic rats. Crocin reduced malondialdehyde 
(MDA) and significantly increased GSH levels in both cardiac tissues and in serum. Besides, 
Crocin improved hyperlipidemia showing that Crocin might prevent diabetes-induced 
cardiovascular complications by reduction of both oxidative stress and dyslipidemia (51). 
Administration of Crocin in diabetic rats resulted in a significant reduction of total oxidant 
level, restored sperm characteristics and testicular damage suggesting that Crocin improves 
most of the reproductive complications of DM (52).  Crocin inhibited pro-inflammatory 
cytokines (TNF-α, IL-6) in the diabetic rats suggesting a therapeutic potential of Crocin in the 
management of diabetes complications (53). 
Multiple sclerosis (MS) 
MS disease is a chronic autoimmune, inflammatory demyelinating disorder of the central 
nervous system (CNS) and can occur in young adulthood (54). The exact etiology of MS 
remains unclear, however, it could be multifactorial including both genetic and environmental 
factors (55). In MS, T-cells and macrophage infiltrations ddestroy myelin sheath in the CNS 
which weakens the transmission of nerve impulses. Two key properties of this disease are acute 
inflammation and demyelination that is accompanied by neuronal degeneration and secondary 
axonal damage(54). Syncytin-1 is a protein activating the pro-inflammatory pathways and 
autoimmune cascades. Syncytin-1 is related to the neuroinflammation as well as 
oligodendrocyte death and is highly expressed in astrocytes, glial cell and microglia of MS 
lesions (56). Saffron has been shown to have a protective effect in autoimmune 
encephalomyelitis (EAE) mice via inhibition of leukocyte infiltration and oxidative stress 
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suggesting Crocin could be of therapeutic potential in the management of MS. It was shown 
that EAE increases the transcript levels of the ER stress genes XBP-1/s. Administration of 
Crocin on day 7 post-EAE induction inhibited ER stress and inflammatory gene expression in 
the spinal cord as well as reduced the expression of ER stress genes XBP-1/s (57). Crocin has 
a neuroprotective effect in vitro against oligodendrocyte cytotoxicity, NO-induced astrocyte 
and syncytin-1, respectively. Besides, Crocin administration on day seven post-EAE induction 
inhibited inflammatory gene expression and ER stress in the spinal cord and decreased 
neuropathology in EAE with less neurological damage. These results demonstrate the roles of 
ER stress and Syncytin-1 in the pathophysiology of MS  and that Crocin could be a potential 
therapeutic agent (58). 
Studies have shown that saffron has anti-neuroinflammatory and antidepressant effects in MS 
as well as Crocin has antidepressant effects in mild to moderate depression. Therefore, saffron 
can be favourably effective in depressive complaints of MS patients (57).  
Molecular mechanism of anti-oxidant activity of Crocin: 
Crocin modifies various molecular mechanisms in cells to perform anti-oxidant activities. One 
of the main activities by Crocin is a change in the expression of genes related in the redox 
system of cells such as glutathione S-transferase (GST), glutathione peroxidase (GPx), catalase 
and superoxide dismutase (SOD). In addition to changes in gene expression levels, interactions 
with cellular enzymes including SOD proteins or peroxidase have also been reported to induce 
the anti-oxidant activity of Crocin (10, 13, 28, 59). Another mechanism underlying the anti-
oxidant activity of Crocin is the alteration of the stress marker genes in the reticuloendothelial 
cell (ER) system. Genes related to ER oxidative stress markers, whose expression is modulated 
by the Crocin are XBP-1/s, BiP, PERK and CHOP (13, 30). Finally, changes in the epigenetics 
and changes in telomerase activity by Crocin are also indicative of the ability of Crocin to 
change at the molecular level of cells and induce anti-oxidant effects of Crocin (60, 61).   
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Conclusion 
Several studies have shown that Crocin is an active component of saffron and could be used 
for the management of various inflammatory diseases. Crocin has shown to have an anti-
oxidant, anti‐inflammatory and antiapoptotic effect. It has been reported that saffron can 
modulate NF-κB and MAPK pathways and can control the expression of genes encoding the 
inflammatory cytokines (e.g. IL-1, IL-2, IL-6, TNF-α), adhesion molecules (e. g., ICAM, 
VCAM, E-selectin), inducible enzymes (such as., COX- 2 and iNOS), chemokines and many 
of the acute phase proteins, all of which play key roles in regulating inflammatory processes in 
the immune system (62). It is believed that excess oxidative stress plays a key role in the 
pathogenesis of ADs by increasing inflammatory mediators, unbalancing the immunological 
tolerance and inducing apoptotic cell death. Evidence shows that Crocin could have a 
therapeutic role in the management of various autoimmune inflammatory diseases such as 
rheumatoid arthritis, T1DM, ulcerative colitis and multiple sclerosis (Table1). More research 
needs to be done on the effects of Crocin in the treatment of other ADs and also clinical studies 
investigating the effects of Crocin. Finally, Crocin modifies various molecular mechanisms in 
cells to perform anti-oxidant activities such as changing in the expression of genes related in 
the redox system of cells, alteration of the stress marker genes in the ER system and changes 
in the epigenetics and telomerase activity of cells.  
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Figure 1: Types of chemical structures of Crocin (63). 
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Autoimmune 
disease 
Dose crocin Experimental 






10, 20 or 40 mg/kg Rats inhibit the expression of 
TNF-α, IL-17, IL-6, CXCL8 
expression levels of MMP-
1, -3 and -13 




6.25, 12.5, 25 
mg/kg 
Sprague Dawley rats reduced the iNOS 
production / TNF-α, IL-1β, 
IL-6 







daily for 1 week 
 
mice blocking NF-κB signalling 










10, 20 mg/kg Wistar rats neutralize MMP-13, MMP-
3 and MMP-9 and HAases  
/TNF-α, IL-1b, NF-kB, IL-6, 
COX-2, PGE2 and ROS 
inhibit exoglycosidases, 
cathepsin-D and tartrate 
resistant acid phosphatases 






0, 50, 100, 200 
ppm 
ICR Mice decrease TNF-α, IL-1β, IL-6, 
IFNγ, NF-κB, COX-2 and 
inducible NO synthase in 






20 mg/kg Sprague Dawley rats Enhance colon anti-oxidant 
defences and reduce colon 
TNF-α, Ca+2 contents, 
enhance Nrf2, HO-1 
activity, reduce CASP3 
activity 






C57BL/6 mice attenuates body weight 
loss, diarrhoea, rectal 
bleeding, colon shortening 





20 mg/kg Wistar rats decrease s MDA, total 
cholesterol, TG, VLDL, 
increases GSH in serum 





40 , 60 mg/kg Wistar rats decreases blood glucose, 
cholesterol, TG, LDL, TOS, 
OSI  
Sefidgar SM et 
al(52) 
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10, 20, 30 mg/kg Wistar rats decreases MDA, NO, total 
lipids, T G, cholesterol 
levels increase GSH, 
catalase, SODs activities, 
inhibits the expression of 
TNFα-IL-6 
Samarghandian 
S et al(53) 
EAE model 100µL saffron 
extract   
C57BL/6 mice Inhibits oxidative 
stress/leukocyte infiltration 
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Table 1: Effects of Crocin on autoimmune diseases. 
 
TNFα:Tumor necrosis factor alpha,IL17: Interleukin 17,IL6: Interleukin 6, CXCL8: Chemokine (C-X-C motif) ligand 8, MMP:Matrix metallopeptidase,  iNOS: 
Inducible nitric oxide synthase, IL1β: Interleukin 1, NF-κB :nuclear factor kappa-light-chain-enhancer of activated B cells, HAases: hyaluronidases, COX-2: 
Cyclooxygenase-2 , PGE2: Prostaglandin E2, ROS: Reactive oxygen species, LPO: Lipid peroxidation, MDA: Malondialdehyde, GSH :glutathione reduction, CAT: 
catalase,  IFNγ: Interferon gamma ,  NO synthases: Nitric oxide synthases, Nrf2: Nuclear factor erythroid 2-related factor 2,  HO-1 : Heme Oxygenase-1, 
CASP3:Caspase-3, TG: Triglyceride, VLDL: Very-low-density lipoprotein , GSH Glutathione, LDL:Low-density lipoprotein , TOS:Total oxidant stress, OSI:Oxidative 
stress index, NO: Nitric oxide , SODs:superoxide dismutases 
 
 
